30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kathryn Falberg

Track

Insider profile

Currently holds positions in Trade Desk Inc, Urogen Pharma Ltd and Tricida Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
36 36% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Trade Desk Inc Aug. 1, 2016 -
Independent Director Urogen Pharma Ltd April 1, 2017 -
Independent Director Tricida Inc May 1, 2018 -
Independent Director Axovant Gene Therapies Ltd April 1, 2017 - Feb. 12, 2018
Non-Executive Independent Director aTyr Pharma Inc July 1, 2014 - May 9, 2017
Director Biomarin Pharmaceutical Inc July 15, 2016 - Jan. 1, 2017
Independent Director Medivation Inc Jan. 31, 2013 - Sept. 28, 2016
Independent Director Halozyme Therapeutics Inc Feb. 1, 2016 - May 4, 2016
Chairman of the Board Halozyme Therapeutics Inc Jan. 1, 2015 - Feb. 1, 2016
Independent Director Halozyme Therapeutics Inc May 16, 2007 - Jan. 1, 2015
Chief Financial Officer, Executive Vice President Jazz Pharmaceuticals PLC March 1, 2012 - March 9, 2014
Independent Director Novelion Therapeutics Inc March 25, 2009 - June 5, 2012
Chief Financial Officer, Senior Vice President Jazz Pharmaceuticals PLC Jan. 1, 2009 - March 1, 2012
Kathryn Falberg's trades of Trade Desk Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-05
S Sale
83,106 +8.0%
38.35
US$4,349,565 		83,106 +8.0% 38.35 US$4,349,565
2026-03-09 2026-03-05
S Sale
89,549 -23.4%
37.17
US$3,039,279 		89,549 -23.4% 37.17 US$3,039,279
2026-03-05 2026-03-05
PrS Proposed sale
15,900
22.88
US$3,998,638 		15,900 22.88 US$3,998,638
2026-03-05 2026-03-05
PrS Proposed sale
117,670
25.00
US$2,941,750 		117,670 25.00 US$2,941,750
2024-08-15 2024-08-13
S Sale
150,000 -60.8%
98.17
US$14,725,500 		150,000 -60.8% 98.17 US$14,725,500
2024-08-13 2024-08-13
PrS Proposed sale
200,000
97.04
US$19,408,000 		200,000 97.04 US$19,408,000
2024-03-12 2024-03-08
S Sale
95 -0.0%
82.36
US$7,824 		95 -0.0% 82.36 US$7,824
2024-03-12 2024-03-08
S Sale
102,935 -29.8%
81.90
US$8,430,376 		102,935 -29.8% 81.90 US$8,430,376
2024-03-08 2024-03-08
PrS Proposed sale
103,030
80.00
US$8,242,400 		103,030 80.00 US$8,242,400
2022-12-05 2022-12-05
B Purchase
43,000 +20.8%
1.95
US$83,962 		43,000 +20.8% 1.95 US$83,962
2022-12-05 2022-12-02
B Purchase
47,000 +29.4%
1.98
US$93,187 		47,000 +29.4% 1.98 US$93,187
2022-12-05 2022-12-01
B Purchase
84,959 +113.2%
1.97
US$167,599 		84,959 +113.2% 1.97 US$167,599
2022-12-05 2022-11-30
B Purchase
75,041 +inf%
1.85
US$139,088 		75,041 +inf% 1.85 US$139,088
2021-11-23 2021-11-19
S Sale
250 -0.5%
110.44
US$27,610 		250 -0.5% 110.44 US$27,610
2021-11-23 2021-11-19
S Sale
21,468 -29.9%
109.98
US$2,361,051 		21,468 -29.9% 109.98 US$2,361,051
2021-11-23 2021-11-19
S Sale
47,719 -40.0%
108.90
US$5,196,599 		47,719 -40.0% 108.90 US$5,196,599
2021-11-23 2021-11-19
S Sale
80,563 -40.3%
108.03
US$8,703,221 		80,563 -40.3% 108.03 US$8,703,221
2021-04-02 2021-03-31
B Purchase
20,000 +24.4%
28.35
US$566,996 		20,000 +24.4% 28.35 US$566,996
2020-11-23 2020-11-19
S Sale
629 -19.2%
822.00
US$517,038 		629 -19.2% 822.00 US$517,038
2020-11-23 2020-11-19
S Sale
13 -0.4%
820.00
US$10,660 		13 -0.4% 820.00 US$10,660
2020-11-23 2020-11-19
S Sale
825 -20.1%
819.06
US$675,724 		825 -20.1% 819.06 US$675,724
2020-11-23 2020-11-19
S Sale
4,139 -50.2%
818.15
US$3,386,323 		4,139 -50.2% 818.15 US$3,386,323
2020-11-23 2020-11-19
S Sale
1,891 -18.7%
815.00
US$1,541,165 		1,891 -18.7% 815.00 US$1,541,165
2020-11-23 2020-11-19
S Sale
10 -0.1%
814.00
US$8,140 		10 -0.1% 814.00 US$8,140
2020-11-23 2020-11-19
S Sale
891 -8.1%
813.04
US$724,419 		891 -8.1% 813.04 US$724,419
2020-11-23 2020-11-19
S Sale
200 -1.8%
811.68
US$162,336 		200 -1.8% 811.68 US$162,336
2020-11-23 2020-11-19
S Sale
5,670 -33.5%
811.00
US$4,598,370 		5,670 -33.5% 811.00 US$4,598,370
2020-11-23 2020-11-19
S Sale
2,852 -14.4%
810.19
US$2,310,662 		2,852 -14.4% 810.19 US$2,310,662
2020-11-23 2020-11-19
S Sale
1,853 -8.6%
809.03
US$1,499,133 		1,853 -8.6% 809.03 US$1,499,133
2020-11-23 2020-11-19
S Sale
795 -3.5%
807.84
US$642,233 		795 -3.5% 807.84 US$642,233
2020-11-23 2020-11-19
S Sale
232 -1.0%
806.63
US$187,138 		232 -1.0% 806.63 US$187,138
2019-06-14 2019-06-13
B Purchase
12,935 +18.7%
8.52
US$110,152 		12,935 +18.7% 8.52 US$110,152
2019-06-13 2019-06-12
B Purchase
10,000 +16.9%
8.49
US$84,928 		10,000 +16.9% 8.49 US$84,928
2019-06-13 2019-06-11
B Purchase
10,000 +20.3%
7.90
US$79,000 		10,000 +20.3% 7.90 US$79,000
2019-06-11 2019-06-10
B Purchase
10,000 +25.5%
8.25
US$82,500 		10,000 +25.5% 8.25 US$82,500
2019-06-11 2019-06-07
B Purchase
22,065 +129.0%
7.99
US$176,297 		22,065 +129.0% 7.99 US$176,297
2019-03-13 2019-03-11
S Sale
40,000 -66.7%
205.47
US$8,218,964 		40,000 -66.7% 205.47 US$8,218,964
2013-08-14 2013-08-14
B Purchase
50,000 +21.7%
6.91
US$345,710 		50,000 +21.7% 6.91 US$345,710
2013-08-14 2013-08-12
B Purchase
50,000 +27.8%
6.72
US$335,935 		50,000 +27.8% 6.72 US$335,935
2012-11-14 2012-11-13
B Purchase
50,000 +45.5%
5.21
US$260,500 		50,000 +45.5% 5.21 US$260,500